Bristol Myers Squibb is a global biopharmaceutical company dedicated to transforming patients' lives through innovative science. With a strong focus on oncology, hematology, immunology, cardiovascular disease, and fibrosis, the company leverages translational medicine and data analytics to develop personalized therapies. BMS fosters a diverse and inclusive workplace culture, driven by a mission to improve health outcomes for all populations.
At RayzeBio, every day is an opportunity to ignite meaningful change. As a wholly-owned subsidiary of Bristol Myers Squibb, RayzeBio blends the nimble, pioneering spirit of an emergent biotech with the global expertise and resources of a leading innovator in oncology.
Bristol Myers Squibb is a global biopharmaceutical company dedicated to transforming patients' lives through innovative science. With a strong focus on oncology, hematology, immunology, cardiovascular disease, and fibrosis, the company leverages translational medicine and data analytics to develop personalized therapies. BMS fosters a diverse and inclusive workplace culture, driven by a mission to improve health outcomes for all populations.
Bristol Myers Squibb